Health Behavior Adherence in a Metropolitan-Based Metabolic Syndrome Management Program during the COVID-19 Pandemic.

Health Behavior Adherence in a Metropolitan-Based Metabolic Syndrome Management Program during the COVID-19 Pandemic.

Publication date: Jan 23, 2024

The COVID-19 pandemic increased the worldwide prevalence of metabolic syndrome. The purpose of this study was to assess health behavior adherence during the pandemic in adults who had engaged in a metabolic syndrome management program for at least six months. This assessment included an evaluation of health behavior changes, factors influencing adherence, and clinical parameters. The city-wide program was operated by the Seoul Metropolitan Government. Baseline and follow-up data were compared in 116 participants who engaged in the program for at least 6 months prior to the pandemic. Health behaviors and clinical parameters were examined. Generalized estimating equation analysis was used to identify sociodemographic variables influencing health behavior adherence over time. Systolic blood pressure, waist circumference, and blood glucose improved (all P

Concepts Keywords
Blood Disease management
Glucose Guideline adherence
Months Health behavior
Seoul Metabolic syndrome
Sociodemographic Republic of Korea

Semantics

Type Source Name
disease MESH Metabolic Syndrome
disease MESH COVID-19 Pandemic
disease VO time
disease IDO blood
drug DRUGBANK Dextrose unspecified form

Original Article

(Visited 1 times, 1 visits today)